Harbin Jixianglong Biotech Co., Ltd. Semaglutide recall: CGMP Deviations This recall has been initiated due to failing to complete
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
The hazard: Sterility or particulate concern
This recall is about sterility assurance. It does not mean every unit is contaminated — it means the manufacturer cannot demonstrate that none of them is.
What the notice says: CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Why it matters: The product was made or packaged in conditions that cannot assure sterility, or visible particles were found in it. For anything injected, infused or used in the eye, that is a direct route for contamination into the body.
Symptoms and when to call a doctor
Watch for fever, chills, pain, redness, swelling or discharge at an injection site, and for a red, painful or suddenly blurred eye after using an eye product. Any of these needs same-day medical attention. Do not wait to see whether it settles, and tell the clinician which product and lot you used so it can be reported against the recall.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0379-2026
- Published
- March 11, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Harbin Jixianglong Biotech Co., Ltd.
- Product type
- Prescription & OTC drugs
- Units affected
- N/A
- Distribution
- Nationwide
- Made in
- China
- Lot / code info
- Lot #: CP-030-20250711, Exp. Date Jul. 24th, 2027
Products covered by this recall
Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04 Manufacturer: Harbin Jixianglong Biotech Co., Ltd., North of Baoan Road, East of Changqing Street, Limin Development Zone, Harbin, China
Check your product
The notice names 9 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- CP-030-20250711
- 2027 — N
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- Jul. 24th
- 2027 — N
NDC number
On the carton and again on the bottle or blister label.
- 84385-106-01
- 84385-106-02
- 84385-106-06
- 84385-106-03
- 84385-106-04
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Sterility
Harbin Jixianglong Biotech Co., Ltd. — This recall is about sterility assurance. It does not mean every unit is contaminated — it means the manufacturer cannot demonstrate that none of them is.
- Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
- Call your prescriber or pharmacy today about a replacement from an unaffected lot — do not simply skip doses of a medicine you depend on.
- If you are a clinic or pharmacy, quarantine the stock and work it through your usual recall log.
- Report any infection or reaction you think the product caused to FDA MedWatch.
Refunds and replacements
With medicines, a replacement supply matters more than cash, and that is what pharmacies are set up to provide.
- Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
- For a mail-order or online pharmacy, use the recall line listed on this page rather than the general support queue.
- If the recall voided a fill you had already paid for, your insurer will normally authorise a replacement ahead of schedule. Quote the recall number.
- If you paid out of pocket, ask for a refund of the co-pay or purchase price and keep the receipt the pharmacy issues.
Company contact: Harbin Jixianglong Biotech Co., Ltd. — North Of Baoan Road, East Of Changqing Street, Haerbin
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Harbin Jixianglong Biotech Co., Ltd. prescription & otc… recalled?
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code CP-030-20250711, 2027 — N; best-by date Jul. 24th or 2027 — N. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
Can I get my money back?
Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 8 months ago
Harbin Jixianglong Biotech Co., Ltd. Semaglutide recall: CGMP Deviations This recall has been initiated due to failing to complete
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before…
-
Class II · 11 days ago
K.C. Pharmaceuticals, Inc. Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 11 days ago
Carolina Infusion, LLC Quad-Mix Injectable, Packaged in single-use dosage syringes recall: Lack of Assurance of Sterility: Related to processing equipment used
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
-
Class II · 11 days ago
Carolina Infusion, LLC Tirzepatide/Cyanocobalamin 26/2 MG/ML Injectable recall: Lack of Assurance of Sterility: Related to formulation using bacteriostic
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
-
Class II · 11 days ago
Carolina Infusion, LLC Tri-MIX ,30/1/20, injectable recall: Lack of Assurance of Sterility: Related to processing equipment used
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
-
Class II · 11 days ago
Carolina Infusion, LLC Tri-MIX ,30/1/10, injectable recall: Lack of Assurance of Sterility: Related to processing equipment used
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.